Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

On Males, Antioxidants and Infertility (MOXI): Certitudes, Uncertainties and Trends

Version 1 : Received: 3 July 2023 / Approved: 4 July 2023 / Online: 4 July 2023 (13:51:39 CEST)

A peer-reviewed article of this Preprint also exists.

Alfaro Gómez, M.; Fernández-Santos, M.R.; Jurado-Campos, A.; Soria-Meneses, P.J.; Montoro Angulo, V.; Soler, A.J.; Garde, J.J.; Rodríguez-Robledo, V. On Males, Antioxidants and Infertility (MOXI): Certitudes, Uncertainties and Trends. Antioxidants 2023, 12, 1626. Alfaro Gómez, M.; Fernández-Santos, M.R.; Jurado-Campos, A.; Soria-Meneses, P.J.; Montoro Angulo, V.; Soler, A.J.; Garde, J.J.; Rodríguez-Robledo, V. On Males, Antioxidants and Infertility (MOXI): Certitudes, Uncertainties and Trends. Antioxidants 2023, 12, 1626.

Abstract

Male infertility (MI) involves various endogenous and exogenous facts. These include oxidative stress (OS), which is known to alter several physiological pathways and it is estimated to be present at high levels in up to 80 % of infertile men. That is why since the late 20th Century, the relationship between OS and MI has been widely studied. New terms have emerged, such as Male Oxidative Stress Infertility (MOSI), which is proposed as a new category to define infertile men with high OS levels. Another important term is MOXI: Male, Antioxidants, and Infertility. Such term refers to the hypothesis that antioxidants could improve male fertility without the use of assisted reproductive technology. However, there is no evidence-based antioxidant treatments that directly improve seminal parameters or birth ratio. In this regard, there is controversy about their use. While certain scientists argue against their use due to the lack of results, others support this use because of their safety profile and low price. Some uncertainties related to the use of antioxidants for treating MI are their questionable efficacy or the difficulties to know their correct dosage. In addition, the lack of quality methods for OS detection can lead to an excessive antioxidant supplementation, resulting in “reductive stress”. Another important problem is that, although the inflammatory process is interdependent and closely linked to OS, it is usually ignored. To solve these uncertainties, new trends have recently emerged. These include the use of molecules with anti-inflammatory and antioxidant potential, and which are also able to specifically target the reproductive tissue; as well as the use of new methods that allow for reliable quantification of OS and a quality diagnosis. This review aims to elucidate the main uncertainties about MOXI and to outline the latest trends in research to achieve effective therapies with clinically relevant outcomes.

Keywords

male infertility; idiopathic; oxidative stress; reductive stress; inflammation; biomarkers; antioxidants

Subject

Chemistry and Materials Science, Analytical Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.